Best Gold Pearlescent Pigment Solutions


Visit us:

Place: Shanghai, China

Factory


Jiangsu Pritty Pearlescent Pigment
Fumin Road 399
223800 Suqian, China

 


Contact

Please contact us for more information

To contact form

sales@prittypigments.com

+86   21 6405 8221

+86 150 2681 0392

 

 

 

 

What are pearlescent pigments?

 

Pearlescent pigments are created by iridescence caused by multiple reflections from two or more semi-transparent surfaces. They consist of mica platelets coated with a thin layer of metallic oxide. This simple structure creates the basis of most pearlescent pigments resulting in a wide variety of different effects. 

 

  • Carrying Platelets
  •  Metallic Oxide Coating
  • Coating Layers and Coating Technology
  • Particle Size Distribution
  • The refractive index of each layer

Pearl effect

Since the beginning of time, mankind has been fascinated with the graceful luster of pearls. A pearl's radiance appears as a three dimensional blush. Objects with pearl's brilliant luster are perceived to be beautiful and precious.

 

Pritty Clareium® for Personal Care Applications

Pritty Clareium® effect pigments are specifically produced for all cosmetic and personal care applications such as:  lipsticks, lip glaze, eye shadow, powder, foundation, and fragrance.  In addition to personal hygiene products such as: toothpaste, shampoo, body lotion, bath and soap.

 

Pritty Clareium® product line heavy metal details

Heavy Metals

Quantify (ppm) Testing Instruments
As < 2 Perking Element Optima (ICP-OPS)
Cd < 3 Perking Element Optima (ICP-OPS)
Hg < 1 Perking Element Optima (ICP-OPS)
Cr < 20 Perking Element Optima (ICP-OPS)
Pb < 10 Perking Element Optima (ICP-OPS)
Ba < 50 Perking Element Optima (ICP-OPS)
Sb < 1 Perking Element Optima (ICP-OPS)
Cu < 20 Perking Element Optima (ICP-OPS)
Ni < 10 Perking Element Optima (ICP-OPS)
Zn < 50 Perking Element Optima (ICP-OPS)

 

 

Pritty Clareium® product line microbiological details

 

 

Tested Items

SSCP Requirements (CFU/G) Test Method
Total number of Aerobic Bacteria ≤ 1 x 102 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Total number of Mold and Yeast ≤ 1 x 102 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Escherichia Coli Absent/ G 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Salmonella Absent / 10G 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Staphylococcus Aureus Absent / G 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Clostridium Absent / G 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Bile'Tolerant Gram-negative Bacteria Absent / G 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Pseudomonas Aeruginosa Absent / G 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA
Candida Albicans Absent / G 7.02.06 12 AND 6.13  EUROPEAN PHARMACOPOEIA